| abstract |
The present invention relates to methyleneurea derivatives of formula I, to the use of compounds of formula I as inhibitors of raf-kinase, to the use of compounds of formula I to prepare a pharmaceutical composition and to a treatment method comprising the administration of said pharmaceutical composition to a patient. |